Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Trade Show

Oncternal Therapeutics to Present at Stifel Healthcare Conference


Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, today announced that James Breitmeyer, M.D., Ph.D., President and Chief Executive Officer, will present a company overview at the Stifel 2019 Healthcare Conference in New York City on Tuesday, November 19, 2019 at 10:20 a.m. ET / 7:20 a.m. PT.

A live webcast of the presentation will be available online via a link from the investor relations page of the Company's website at www.oncternal.com, and the webcast will be archived there for at least 30 days following the event.

About Oncternal Therapeutics

Oncternal Therapeutics is a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies for the treatment of cancers with critical unmet medical need. Oncternal focuses drug development on promising yet untapped biological pathways implicated in cancer generation or progression. The pipeline includes cirmtuzumab, an investigational monoclonal antibody designed to inhibit the ROR1 pathway, a type I tyrosine kinase-like orphan receptor, that is being evaluated in a Phase 1/2 clinical trial in combination with ibrutinib for the treatment of chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL), and TK216, an investigational small-molecule compound that is designed to inhibit E26 transformation specific (ETS) family oncoproteins, that is being evaluated in a Phase 1 clinical trial for patients with Ewing sarcoma alone and in combination with vincristine chemotherapy. In addition, Oncternal has a program to develop a CAR-T therapy that targets ROR1, which is currently in preclinical development as a potential treatment for hematologic cancers and solid tumors. More information is available at www.oncternal.com.


These press releases may also interest you

at 09:10
Using online estimates will tell the policyholders if they still pay fair prices for their coverage. Comparing prices from multiple companies will help drivers have a better view of the market. When shopping online, it is important to follow the next...

at 09:00
On February 18, 2020, the second online course of ALLPCB, Four-Step Method of WeChat Marketing, arrived as scheduled. Led by the director of Training Center, jointly researched by Training Center and Sales Center, this course aims to provide sales...

at 08:26
Phoenix Contact, a digital industrial company is set to participate at the upcoming Middle East Energy Exhibition (formerly known as Middle East Electricity), the global energy platform. The Phoenix Contact stand will be located at booth number 6A10...

at 07:00
From RSA 2020, Wallarm has released an expanded set of parsers, detection of API-specific vulnerabilities and API schema analysis for gRPC and GraphQL. With Wallarm context-specific protection is delivered both for externally-facing APIs and for...

at 06:49
Cellcom Israel Ltd. (the "Company") announced today that Mr. Ami Erel, the Company's Chairman of the Board of Directors, informed the Company of his resignation from the board of directors, effective March 1, 2020. About Cellcom Israel Cellcom...

22 fév 2020
Sky Seal Capital announces Phoenix Lending, a platform that allows users to deposit digital asset and earn interest. Phoenix Lending has been launched from February 1 to March 1 in several phases introducing products of different annualized...



News published on 11 november 2019 at 08:05 and distributed by: